Listed by the USPTO as BOWERS, ERIN M
Tech Center 1600 • Art Units: 1653 1675 1681 1693
This examiner grants 55% of resolved cases
BOWERS, ERIN M is a USPTO patent examiner in tech center 1600 and art unit 1653. The profile records 555 resolved cases and an allowance rate of 54.8%. The median time to allowance is 1286 days.
The interview lift is 10.0%, showing a positive but limited association between interviews and allowance outcomes. The listed companies are Promega Corporation, Animal Microbiome Analytics, Inc., and Takeda Pharmaceutical Company Limited. The listed firms are Casimir Jones, S.C., BakerHostetler, and GOODWIN PROCTER LLP. The combination of a mid-range allowance rate and extended pendency supports early evaluation of claim scope and deliberate response sequencing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18611181 | TWO COMBINED MUTATIONS THAT INTRODUCE THE SECOND ENTRY PATHWAY TO SYNTHESIZED LIGNIN FROM TYROSINE IN PLANTS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18930737 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18593314 | CONJUGATES AND METHODS OF USE THEREOF | Non-Final OA | Regents of the University of Minnesota |
| 18883789 | METHOD TO INCREASE DRUG SUBSTANCE YIELD | Final Rejection | PharmaEssentia Corporation |
| 18669411 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | Non-Final OA | Northwestern University |
| 18626999 | COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18700134 | ENDOGLUCANASE WITH IMPROVED STABILITY | Non-Final OA | Novozymes A/S |
| 17177591 | CELL CULTURE METHOD AND CELL CULTURE APPARATUS | Final Rejection | NIKKISO CO., LTD. |
| 18660851 | RNA POLYMERASE VARIANTS | Non-Final OA | Codexis, Inc. |
| 18701413 | GLUCOAMYLASE VARIANTS AND METHODS FOR USE THEREOF | Non-Final OA | DANISCO US INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.8% of resolved applications examined by Erin M Bowers were allowed (555 resolved cases), compared with 23.3% across Art Unit 1653 over the last five years.
This examiner's interview lift is +10.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Erin M Bowers took 1,286 days on average from filing to allowance.
Erin M Bowers examines applications in Art Unit 1653 in Tech Center 1600 (Biotechnology & Pharmaceuticals).